U.S. Patent
BIO 2017
National Cancer Conference
Cancer Research News- Study Finds Wide County-Level Variation in Rates of Surgery for Early-Stage Lung Cancer December 5, 2019Socioeconomic and healthcare delivery factors appear to contribute to the gap
- American Cancer Society & Flatiron Health Launch Real-World Data Impact Award December 4, 2019Grant seeks to support patient-centric research through funding and access to real-world oncology datasets
- American Cancer Society Updates Position on Electronic Cigarettes November 19, 2019Newer, Clearer Guidance Offered in Light of Public Health Trends and Lack of Regulation
- The 44th Great American Smokeout: Higher Smoking Rates Persist among Some Populations November 15, 2019
- American Cancer Society Announces New Video Series Created to Deliver Clinical and Emotional Support to Cancer Caregivers November 1, 2019Partnering with Actress, Author and Entrepreneur NeNe Leakes to Share Caregiving Experience for National Family Caregivers Month
- Study Finds Wide County-Level Variation in Rates of Surgery for Early-Stage Lung Cancer December 5, 2019
Health Care Forum “War on Cancer” (March 30th 2017-Singapore)
Author Archives: czbiomed_t0k2xz
Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment
Kocal Consulting Corporation Announces Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment Well Marker Bio Co. Ltd., a biotech division of Asan Medical Center of South Korea, signs Memorandum of Understanding with CZ Biomed Corp. and Kocal … Continue reading
Posted in Uncategorized
Leave a comment
Partnerships with Bio-pharmaceutical Leaders
Kocal Consulting Corporation Celebrates new Consulting Agreement with CZ Biomed Corp to Help Deliver Real Value to Bio-pharmaceutical World Bio-pharmaceutical insiders have long known about the important, diverse work being done by CZ Biomed Corp, some of which could have … Continue reading
Posted in Cancer News, Colon Cancer, Prostate Cancer
Leave a comment
Oncolytic Virus Reduces Prostate Cancer
Oncolytic Virus Genetically Engineered from “Respiratory Syncytial Virus” (RSV) Reduces Prostate Cancer Tumors More Than 50% Press Release CZ BioMed Corp. Announces Successful Reduction of Prostate Cancer Tumors More Than 50% Using PRO-RVLYSIS(R) TAMPA, FL, August 26, 2013 – CZ … Continue reading
Posted in Prostate Cancer
Leave a comment
Oncolytic Virus Success Treating Colon Cancer
Oncolytic Virus “Respiratory Syncytial Virus” (RSV) Genetically Engineered to Treat Various Cancers Shows Stunning Results in Treating Colon Cancer Press Release – November 11, 2015 CZ BioMed Corp. Announces 2.5 Year Survival of Stage 4 Colon Cancer Patient. Cancer Free … Continue reading
Posted in Colon Cancer
Leave a comment
